TMO Financial Facts
Cost of product revenues: 1.53BNet Income: 336.2M
See Full Income Statement
Total current liabilities: 2.3B
Total shareholders' equity: 15.6B
See Full Balance Sheet
Earnings History for Thermo Fisher Scientific, Inc. (TMO)
|
Expand Research on TMO
| Next EPS Date | 7/24/13 *Est. | EPS Growth Rate | +17.1% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +5.1% | Revenue Growth Rate | +2.9% *Last Qtr. |
| Average % Move 1-Wk after EPS | +5.7% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/24/13  |
 |
Q113 | $1.37 | $1.29 | +$0.08 | $3.19B | $3.17B | N/A / N/A |  |
+8.4% | Details |
| 1/31/13 |
|
Q412 | $1.36 | $1.28 | +$0.08 | $3.26B | $3.13B | N/A / N/A | |
+24.2% | Details |
| 10/24/12 |
|
Q312 | $1.19 | $1.16 | +$0.03 | $3.09B | $2.99B | N/A / N/A |  |
+51.7% | Details |
| 7/25/12 |
|
Q212 | $1.22 | $1.16 | +$0.06 | $3.11B | $3.05B | N/A / N/A | |
+75.6% | Details |
| 4/25/12 |
|
Q112 | $1.17 | $1.10 | +$0.07 | $3.1B | $2.97B | N/A / N/A | |
+65.7% | Details |
| 2/1/12 |
|
Q411 | $1.18 | $1.15 | +$0.03 | $3.13B | $3.08B | N/A / N/A | |
+65.2% | Details |
| 10/26/11 |
|
Q311 | $1.07 | $1.07 | $0.00 | $2.97B | $3B | N/A / N/A | = | +64.2% | Details |
| 7/27/11 |
|
Q211 | $0.99 | $0.98 | +$0.01 | $2.9B | $2.84B | N/A / N/A | = | +42% | Details |
